Prostate-specific antigen, its molecular forms, and other kallikrein markers for detection of prostate cancer - 01/09/11
Doi : 10.1016/S0090-4295(01)01449-2
Carsten Stephan a, b, Klaus Jung ⁎, a, Eleftherios P Diamandis b, c, Harry G Rittenhouse d, Michael Lein a, Stefan A Loening a
a Department of Urology, University Hospital Charité, Humboldt University Berlin, Berlin, Germany
b Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
c Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
d Hybritech Incorporated, a Subsidiary of Beckman Coulter, Inc., San Diego, California, USA
*Reprint requests: Klaus Jung, M.D., Department of Urology, University Hospital Charité, Humboldt University Berlin, Schumannstrasse 20/21, Berlin D-10098, Germany
Plan
 | This work was supported in part by a grant from MSD to C. Stephan. |
© 2002
Elsevier Science Inc. Tous droits réservés.
Vol 59 - N° 1
P. 2-8 - janvier 2002 Retour au numéro
Article précédent
- Letter from the editor
- Mechanisms of immune evasion by renal cell carcinoma: tumor-induced T-lymphocyte apoptosis and NFκB suppression
- Christopher S Ng, Andrew C Novick, Charles S Tannenbaum, Ronald M Bukowski, James H Finke
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?